FDA

The investigation of the AGGA involved interviews with 11 patients who said they were hurt by the device and dental specialists who said they’d examined patients who had experienced severe complications using the AGGA.

The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.

States will be able to request doses of the prescription flu medication Tamiflu kept in the Strategic National Stockpile. The Biden administration is not releasing how many doses will be made available.

Colorado, New Hampshire and New Mexico are also seeking federal permission to import cost-saving prescription drugs from Canada. President Joe Biden endorsed the approach in his 2020 campaign but has yet to approve any state plan.

Increasingly, the FDA is asking drugmakers to remove unproven uses from older drugs that haven't delivered on early results. And drugmakers seeking accelerated approvals are facing tougher hurdles.

The popularity of at-home COVID tests has amplified calls from health researchers and diagnostic companies to make testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.

Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.

Frank Jones didn't see the truck that just missed him. Didn't hear it either. Though he has gone to an audiologist, he says cost has held him back from getting hearing aids. A new FDA policy could change that.

Lori McClintock, the wife of U.S. Rep. Tom McClintock of California, died after ingesting white mulberry leaf, according to the Sacramento County coroner.

Demand could delay when the vaccine is available, but the state's refusal to preorder from the federal government won't be the reason, says the director of infection prevention at UF Health Jacksonville.

The FDA could authorize the shots for emergency use with young children this week, but Florida Surgeon General Dr. Joseph Ladapo says there is insufficient data to "inform benefits and risk."

U.S. regulators have historically inspected baby formula plants at least once a year, but they did not inspect any of the three biggest manufacturers in 2020, according to federal records reviewed by AP.